Nonmotor Symptoms in Dopa-Responsive Dystonia

Area of Science:

• Neurology
• Genetics
• Neuropharmacology

Background:

• Dopa-responsive dystonia (DRD) is a rare, inherited disorder caused by mutations in the GCH1 gene, affecting tetrahydrobiopterin biosynthesis.
• DRD typically presents with early-onset lower-limb dystonia, parkinsonism, and a significant response to levodopa.
• The broader impact of tetrahydrobiopterin deficiency on non-motor functions in DRD remains under-explored.

Purpose of the Study:

• To comprehensively review and analyze published data on non-motor symptoms associated with Dopa-responsive dystonia (DRD).
• To consolidate current understanding of the non-motor clinical spectrum in DRD.
• To identify gaps in knowledge regarding non-motor manifestations.

Main Methods:

• Systematic literature search of the Medline database.
• In-depth analysis of publications from 1971 to March 2015.
• Focus on studies reporting non-motor symptoms in patients with DRD.

Main Results:

• Depression and impaired sleep quality are frequently reported non-motor symptoms in DRD cohorts.
• Current evidence does not support significant alterations in cardiologic or autonomic systems in DRD.
• The role of non-motor symptoms, including sleep disorders and cognitive function, requires further investigation, with some data suggesting potential mimicry with other neurotransmitter disorders.

Conclusions:

• Non-motor symptoms, particularly depression and sleep disturbances, are relevant aspects of the DRD clinical spectrum.
• Further research involving larger, treatment-naïve populations is essential to fully characterize non-motor symptoms in DRD.
• Consideration of non-motor symptoms in diagnostic and therapeutic strategies for DRD is warranted.